Does Rallies show 13F holders for MRKR?

Yes. Rallies tracks hedge fund and 13F ownership data for MRKR, including fund names, share counts, latest tracked quarter, and position changes when available.

Is MRKR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MRKR. It does not provide personalized investment advice.

MRKR (Marker Therapeutics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Marker Therapeutics, Inc. Common Stock (MRKR) is a publicly traded Healthcare sector company. As of May 21, 2026, MRKR trades at $1.41 with a market cap of $23.18M and a P/E ratio of -2.33. MRKR moved +2.16% today. Year to date, MRKR is -21.23%; over the trailing twelve months it is +23.68%. Its 52-week range spans $0.81 to $5.95. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces MRKR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns MRKR stock?

Hedge funds tracked by Rallies that own MRKR include Renaissance Technologies. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Marker Therapeutics, Inc. Common Stock.

MRKR Key Metrics

Key financial metrics for MRKR
Metric	Value
Price	$1.41
Market Cap	$23.18M
P/E Ratio	-2.33
EPS	$-0.61
Dividend Yield	0.00%
52-Week High	$5.95
52-Week Low	$0.81
Volume	3.84K
Avg Volume	0
Revenue (TTM)	$3.95M
Net Income	$-10.90M
Gross Margin	0.00%

Top Hedge Funds Holding MRKR

Renaissance Technologies holds 40.05K shares of MRKR, changed +0.75% as of Dec 31, 2024.

Latest MRKR News

Marker Therapeutics Posts 66% Response Rate, Secures $17M to Fund Runway Through Q4 — Mar 18, 2026

Recent MRKR Insider Trades

ELMS STEVE bought 11.09K (~$35.47K) on Dec 23, 2024.
New Enterprise Associates 16, L.P. bought 554.25K (~$1.77M) on Dec 23, 2024.
Wasserman Frederick Gerald bought 10.00K (~$24.10K) on May 18, 2021.

MRKR Analyst Consensus

2 analysts cover MRKR: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.00.

Common questions about MRKR

Who owns MRKR stock?: Hedge funds tracked by Rallies that own MRKR include Renaissance Technologies. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Marker Therapeutics, Inc. Common Stock.
Does Rallies show 13F holders for MRKR?: Yes. Rallies tracks hedge fund and 13F ownership data for MRKR, including fund names, share counts, latest tracked quarter, and position changes when available.
Is MRKR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MRKR. It does not provide personalized investment advice.